BOTHELL,
Wash., Feb. 20, 2024 /PRNewswire/ -- BioLife
Solutions, Inc. (NASDAQ: BLFS), a leading supplier of
class-defining bioproduction tools and services for the cell and
gene therapies ("CGT") and broader biopharma markets, today
announced the Company's fourth quarter and full year 2023 financial
results will be released after market close on Thursday, February 29, 2024. The Company will
host a conference call and live webcast at 4:30pm ET (1:30pm
PT) that day. Management will provide an overview of the
Company's financial results and give a general business update.
To access the webcast, log onto the Investor Relations page of
the BioLife Solutions website
at https://www.biolifesolutions.com/earnings. In
addition, the conference call will be accessible by dialing
toll-free 1-833-630-0431 or 1-412-317-1808 for international
callers. The conference ID number is 29175. A webcast replay will
be available approximately two hours after the call and will be
archived on https://investors.biolifesolutions.com for 90
days. If you would like to pre-register for this call, please use
this pre-registration link.
About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining
bioproduction tools and services for the cell and gene therapy
(CGT) and broader biopharma markets. Our expertise facilitates the
commercialization of new therapies by supplying solutions that
maintain the health and function of biologic materials during
collection, development, storage, and distribution. For more
information, please visit www.biolifesolutions.com or follow
BioLife on LinkedIn and X.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-fourth-quarter-and-full-year-2023-financial-results-and-business-update-on-february-29-2024-302064629.html
SOURCE BioLife Solutions, Inc.